Maintenance dosing (1-2mg 2-3x weekly or daily topical) sustains improvements indefinitely, positioning GHK-Cu as a long-term anti-aging strategy rather than a one-time fix
Frequently Asked Questions What is the difference between GHK-CU and Copper Tripeptide-1
The publisher, authors, editors, syndication partners, and all distribution platforms make no warranties or representations regarding the completeness, accuracy, or reliability of the information and expressly disclaim any and all liability for any losses, damages, or harm resulting from the use or misuse of any product referenced in this content
These formulations push concentration toward practical limits for topical application
Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides